Description
Pharmaceutical Intermediate High Purity Crystalline Powder Uracil CAS 66-22-8
Description
| Product Name: | Uracil | Other Name: | 2,6-Dihydroxypyrimidine |
|---|---|---|---|
| CAS No: | 66-22-8 | Purity: | 99% Min |
| Shelf Life: | 2 Years | Application: | Medication |
| Sample: | Available | Storage: | Cool And Dry Place |
| Appearance: | White Powder |
Pharmaceutical Intermediate High Purity Crystalline Powder Uracil CAS 66-22-8
Product Introduction
Name: Uracil
English synonyms: 2,6-Dihydroxypyrimidine
CAS Number: 66-22-8
Molecular formula: C4H4N2O2
Molecular weight: 112.09
EINECS number: 200-621-9
Product Description
Melting point: >300°C(lit.)
Boiling point: 209.98°C(rough estimate)
Density: 1.4421(rough estimate)
Refractive index: 1.4610(estimate)
Storage conditions: 2-8°C
Acidity coefficient (pKa): 9.45(at25℃)
Form: Crystalline Powder
Color: White to slightly yellow
Water solubility: SOLUBLE IN HOT WATER
Stability: Stable. Incompatible with strong oxidizing agents.
Product Function
Uracil can block the degradation of tegafur, increase the concentration of fluorouracil, and enhance the anti-cancer effect. The clinical indication is the same as that of fluorouracil. It is mainly used for digestive system cancer, breast cancer and thyroid cancer, etc., and it has a good effect when combined with mitomycin in advanced gastric cancer. The laboratory obtains uracil through the cyclization of urea and ethyl formylacetate. Used in medicine and biochemical research.
